NBP · Forms 3, 4, 5
Insider trades at NovaBridge Biosciences
3 insiders sold $88K of NovaBridge Biosciences stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for NovaBridge Biosciences (NBP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Phillip Andrew Dennis | Chief Medical Officer | Sell | 8,209 | $0.71 | $6K | Form 4 | |
| Phillip Andrew Dennis | Chief Medical Officer | Option exercise | 23,695 | Form 4 | |||
| Martin William Dewhurst | Director | Became an insider (Form 3) | Form 3 | ||||
| Sean Wuxiong Cao | Chief Bus. Development Officer | Sell | 107,978 | $0.74 | $80K | Form 4 | |
| Sean Wuxiong Cao | Chief Bus. Development Officer | Option exercise | 235,136 | Form 4 | |||
| Sean Wuxiong Cao | Chief Bus. Development Officer | Option exercise | 104,236 | Form 4 | |||
| Cong Claire Xu | EVP, Clinical Development | Sell | 3,282 | $0.79 | $3K | Form 4 | |
| Cong Claire Xu | EVP, Clinical Development | Option exercise | 9,382 | Form 4 | |||
| Robert A. Lenz | Director | Option exercise | 17,218 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.